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/ T Cells Act
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Institute of Human Histology, University of Liege, rue de Pitteurs, 20, B-4020 Liege, Belgium
We have isolated two subtypes of helper T cells from human tonsils: CD4 CD57 cells,
mostly located in the germinal center (GC), and CD4 CD57- cells, distributed through the
interfollicular areas but also present in the GC. In a functional study, we have compared the
capacities of these T-cell subtypes to stimulate B cells in cocultures. In order to block T-cell
proliferation while maintaining their activation level, we pretreated isolated T cells with
mitomycin C prior to culture in the presence of B cells and added polyclonal activators such
as PHA and Con A, combined or not with IL-2. Contrary to CD4/CD57- cells,
CD4 CD57 cells did not markedly enhance B-cell proliferation. Even when sIgD-B cells
typical of germinal center cells were tested, the CD4 CD57 cells had no significant effect.
This is in accordance with the location of these cells: They mainly occupy the light zones
of the GC where few B cells divide. Even when added to preactivated, actively proliferating
cells, CD4 CD57 cells failed to modulate B-cell multiplication. On the supernatants of
B-cell-T-cell cocultures, we examined by the ELISA technique the effect of T cells on Ig
synthesis. Contrary to CD57- T cells, whose effect was strong, CD57 T cells weakly
stimulated Ig synthesis. More IgM than IgG was generally found. Because CD57 antigen is
a typical marker of natural killer cells, we tested the cytolytic activity of tonsillar
CD4/CD57 cells on K562 target cells. Unlike NK cells, neither CD4+CD57 nor
CD4 CD57- cells exhibit any cytotoxicity. Thus, germinal center CD4 CD57 cells are not
cytolytic and do not strongly stimulate either B-cell proliferation or Ig secretion.
CD4 CD57- cells, however, enhance B-cell proliferation and differentiation, thus acting
like the classical helper cells of the T-dependent areas.
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INTRODUCTION
T lymphocytes purified from human tonsils are
mainly CD4 cells (Sugiyama et al., 1976, 1984,
1987; Plum et al., 1987), CD8 T cells being
proportionally less numerous in tonsils than in the
peripheral blood (Sugiyama et al., 1987). The prev-
alence of CD4 cells in tonsils suggests that tonsillar
T lymphocytes are functionally oriented to helper
activity (Sugiyama et al., 1987). Several immunohis-
tochemical studies have revealed the existence of
tonsillar T cells expressing the CD57 antigen char-
acteristic of cells with NK activity (Okada et al.,
1988). These cells are essentially located in the GC
light zone; a few are also found in the interfollicular
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T-dependent areas and the mantle zones (Bouza-
hzah et al., 1993). In a previous ultrastrutural
morphological study, we have shown that these
cells are medium-sized and do not contain the large
granules typical of blood NK cells (Bouzahzah et al.,
1993). Phenotypically, these cells do not express Leu
8, CD16, or CD11b, so they clearly differ from
classical NK cells (Si and Whiteside, 1983; Verlardi
et al., 1985, 1986a). These CD4 CD57 cells do not
express CD25 (IL-2 receptor), CD71 (transferrin
receptor), or HLA-DR, but do express CD69 (Bowen
et al., 1991). Thus, they should be viewed as
preactivated rather than fully activated cells. Their
ability to produce cytokines is much debated
(Velardi et al., 1986b; Bosseloir et al., 1989, 1991;
Bowen et al., 1991; Butch 1993).
There is no available data as to the function of
CD4 /CD57 /cells. In this report, we compare the
effects of CD4 CD57 and CD4 CD57- cells on
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B-cell proliferation and differentiation in Ig-
secreting cells. Using several procedures (nylon
wool columns, and selections by dynabeads and
MACS), we have purified both populations of T-
helper cells and cocultured them with B cells iso-
lated from tonsils. We have compared the capacity
of B cells to incorporate tritiated thymidine or to
produce IgM or IgG in these two types of coculture.
We pretreated the T-cell populations with mitomy-
cin C to prevent their multiplication but added
various activators to the cultures. In another series
of experiments, we tested the cytotoxicity of
CD4 CD57- and CD4 CD57 in the presence of
K562 target cells.
RESULTS
Effects of CD57 and CD57- T Cells on B-cell
Proliferation
To test the effects of CD57 and CD57- cells on
B-cell proliferation, cell populations enriched in
these cells were added to highly purified B cells. The
purity of the T-cell populations used, as estimated
by flow cytometry, exceeded 94% (CD57 cells) or
96% (CD57- cells). Before being cocultured, the
T-cell populations were treated with mitomycin C to
minimize their capacity to incorporate [3H]-
thymidine. The cells were stimulated, however,
with PHA (2 tg/ml) to keep them activated. As a
control, B cells were cultured alone. Little or no
proliferative activity was observed in B-cell popula-
tions cultured alone or in mitomycin-C-treated T
cells. Coculturing with unsorted CD4 T cells or
with purified CD4 CD57- cells markedly increased
B-cell proliferation (Fig. 1). CD57 cells had only a
very slight enhancing effect on B-cell proliferation.
Next, we reasoned that germinal center B cells might
react differently than the total B-cell population.
Therefore, after eliminating IgD cells from the
total tonsillar B-cell population, we cocultured either
the total B-cell population or the sorted IgD- B cells
with mitomycin-C-treated T cells in the presence of
PHA (Fig. 2). The results obtained were similar to
those of the previous experiments: the CD57+T
cells exerted only a weak enhancing effect on B or
IgD- cell proliferation in-comparison to the marked
effect of CD57- T cells.
The previous experiments showed that CD57 T
cells only slightly increase the proliferative activity
of B cells. Considering that these CD5 7 cells might
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FIGURE 1. Proliferation of B cells in presence of CD57 or
CD57- cells. B cells (105 cells per well) were incubated with the
CD57 or CD57- cells (3 x 105 cells/well) and examined for
proliferation after 48 hours of culture. The CD57 and CD57-
cells were pretreated with mitomycin C (50 Iag/ml for 45 min) and
activated with PHA (2 tg/ml). Levels of tritiated thymidine up-
take are indicated in CPM. The results are expressed as the mean
of quadriplicate cultures and are representative of 4 experiments
performed. In 1: B cells alone; 2: B cells and CD57 cells; 3: B cells
and CD57- cells; 4: B cells and unsorted CD4 cells.
not be sensitive to PHA, we performed a new series
of experiments in which mitomycin-C-treated
CD57 or CD57- cells were cocultured with B cells
in the presence of PHA or ConA, combined or not
with IL-2. B-cell proliferation was measured after 48
hours (Fig. 3). Addition of IL-2 to PHA only slightly
improved the uptake of tritiated thymidine by B
cells cocultured with the CD57 cells. A much
better response was measured when these cells
were stimulated with ConA and IL-2. Similar results
were obtained in cocultures of B and CD57-T cells,
but the level of proliferation was greater than in
cultures composed of B and CD57 cells. None of
the activators used (ConA, PHA, IL-2) elicited any
significant proliferative response in B cells cultured
without T cells.
Effects of CD57 and CD57- Cells on the
Proliferative Activity of Preactivated B Cells
The previous experiments were performed with
freshly isolated B and T cells. To see whether the
T-cell population might inhibit active B-cell prolif-
eration, the B cells were preactivated for 24 hours
with SAC or with anti-CD40 antibody combined
with anti-Ig (respectively at 100 ng/ml and 1/600).
The sorted T cells were treated with mitomycin C
before coculturing with preactivated B cells. PHA
was included throughout the culture period.GERMINAL CENTER T-HELPER CELLS 191
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FIGURE 2. Proliferation of unsorted B cells or IgD-B cells in presence of CD57 or CD57- cells. B cells or sIgD-B cells (105 cell
per well) were cocultured with mitomycin-C-treated CD57 or CD57- cells (3 x 105 g/well), sIgD- cells were sorted using anti-IgD-
mAb and the MACS procedure. PHA was added whole during culture duration to maintain T-cell activation. B-cell proliferation was
measured after 48 hours. The results are expressed as the mean of quadriplicate cultures. In 1: B cells and sIgD cells alone; 2: B cells
and sIgD- cells and CD57 3: B cells and sIgD- cells and CD57-.
As shown in Fig. 4, the proliferation of B cells
alone was markedly increased in the presence of all
the different activators. Addition of CD57 cells
increased the proliferative response when the B cells
were stimulated with SAC, but not when they were
preactivated with anti-Ig and anti-CD40. Addition
of CD57- T cells was always followed by marked
stimulation of the preactived B cells.
Effects of CD57 or CD57- T Cells on Ig
Secretion
Tonsillar B cells were cultured alone or in the
presence of mitomycin treated CD57 or CD57- T
cells. The ratio of T to B cells was 3/1. PHA or
ConA, combined or not with IL-2, was added as a
stimulator to the culture medium. The supernatants
TABLE
Effect of CD57 or CD57- Cells on Ig Production
Addition to Culture Medium
Secreted Ig (ng/ml)
IgM IgG
B cells + PHA + IL2
Bcells + ConA + IL2
B cells alone
B cells + CD57 cells + PHA
B cells + CD57 cells + PHA + IL2
B cells + CD57 cells + ConA
B cells + CD57 cells + ConA + IL2
B cells + CD57-cells + PHA
B cells + CD57-cells + PHA + IL2
B cells + CD57-cells + ConA
B cells + CD57-cells + ConA + IL2
600 + 48 994 + 180
600 + 48 < 733
600 + 48 760 + 225
600+48 922+ 180
3,216+211 1,899+225
2,544 + 192 594 + 57,6
3,609 + 240 877 + 180
3,580 + 259 3,271 + 495
10,170 + 1,350 5,566 + 644
3,926 + 384 < 733
11,475 + 1,485 733 + 180
Purified tonsillar B cells 105) cocultured with mitomycin-C-treated CD57 CD57- cells (3 105) in 96-well plates in total volume of 200 tl per well in
presence of different combinations of activators (PHA; gg/ml; ConA: 10 gg/ml; IL-2:10 U/ml). After 10 days, the culture supernatants harvested and analyzed for
the presence of IgG and IgM by specific ELISA. The results representative of experiments.192 F. BOUZAHZAH et al.
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FIGURE 3. Proliferation of B cells in presence of CD57 or CD57- cells and different activators. B cells (105 cells/well) were
cocultured with mitomycin-C-treated T cells (3 x 105 cells/well). Tritiated thymidin incorporation was measured after 48 hours. No
or very low proliferative activity was observed in B cells cultured alone or in mitomycin-C-treated T-cell populations. T cells (CD57
or CD57-) were activated with PHA (2 g/ml) or Con A (10 g/ml) combined or not to IL-2 (10 U/ml): 1: PHA; 2: PHA and IL-2;
3: ConA; 4: ConA and IL-2. These results are representative of 3 experiments performed and are expressed as the mean of
quadriplicate cultures.
were collected after 10 days of culture and their IgM
and IgG contents analyzed by ELISA. The results are
presented in Table 1, B cells cultured alone did not
produce large amounts of Ig. Addition of T cells
generally increased Ig synthesis, CD57- T cells
being much more effective than CD57 /T cells. IgM
were secreted in larger quantities than IgG, espe-
cially when IL-2 was present in the medium. ConA
was a better inducer of IgM production than PHA,
but less effective than PHA at increasing IgG secre-
tion. Thus, IgM secretion was highest when B cells
were cocultured with CD57- T cells stimulated by
ConA and IL-2, whereas IgG secretion was highest
in B cells cocultured with CD57- cells stimulated
with PHA and IL-2.
Cytolytic Activity of CD57 and CD57- T
Cells
Neither freshly isolated nor preactivated CD57 or
CD57- cells exerted any cytolytic activity against
K562 target cells. Comparatively high cytolytic ac-
tivity was measured in the positive controls: for
example, 60% 51Cr release at 20:1 and 50% at 10:1
(effector: target ratio).
DISCUSSION
Helper activity toward B lymphocytes can efficiently
be induced in vitro by stimulation of human T cells
with various mitogens (Hirohata et al., 1988;
Patel et al., 1993; Dembech et al., 1992). In this
report, we examine the effect of CD4 CD57 and
CD4/CD57- tonsillar T-cell populations on the
proliferation and terminal differentiation of B cells
isolated from tonsils.
The CD4 /CD57- cells are representative of the
T-cell populations of the interfollicular areas and
GC, whereas the CD4 CD57 are essentially GC T
cells. Although the CD57 Ag is also expressed by
NK cells, the tonsillar CD57 cells are morpholog-GERMINAL CENTER T-HELPER CELLS 193
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FIGURE 4. Effect of CD57 or CD57- cells on the proliferation of preactivated B cell. B cells (105 cells) were preactivated with:
1:SAC (at a final dilution of 1/10,000) or 2: anti-Ig combined to anti-CD40 (respectively at 1/600 and 100 ng/ml). After 24 hours
of culture, mitomycin-C-treated CD57- or CD57 cells (3 x 105 cells/well) were added in presence of PHA (2 lag/ml). Thymidin
incorporation by B cells was measured after 48 hours. Results are expressed as the mean of quadriplicate cultures and are
representative of 5 experiments.
ically and functionally different. We have, in fact,
evaluated the cytolytic activity of these cells by the
51Cr release method, using human K562 cell as
targets. Unlike classical NK cells, tonsillar
CD4 CD57 manifest no NK activity, even when
preactivated with PHA for 24 hours. Our results
agree with those of Velardi et al. (1986a, 1986b).
Thus, expression of this NK-related antigen does not
reflect a cell’s cytolytic potential, but characterizes a
subset of CD4 T-helper cells in germinal centers.
When CD57- or CD57 cells were cocultured
with B cells, B-cell proliferation was slightly in-
creased by the CD5 7 cells but enhanced thirty-fold
in the presence of CD57- cells or unsorted CD4
cells. This finding is in line with results reported by
Velardi et al. (1986b) showing that CD57 cells do
not produce B-cell growth factors. Several studies
have indicated that a subpopulation of germinal
center B cells can proliferate in response to low
concentrations of IL-2 (Forman and Pure, 1991). In
our experiments, CD57 T cells did favor B-cell
proliferation when IL-2 was added to the medium.
IL-2 by itself was not sufficient to stimulate B-cell
proliferation, because B cells cultured alone in the
presence of IL-2, combined or not with PHA or
ConA, failed to proliferate. IL-2 appears to act on T
cells, which then stimulate B cells. This activation
requires also direct T-cell-B-cell interaction (Clark
and Lane, 1991; Tohma and Lipsky, 1991; Liu et al.,
1992; MacLennan et al., 1992; Moller, 1992) be-
cause physical separation of the two cell types with
a semipermeable membrane precludes B-cell activa-
tion. Cytokines, particularly IL-2 (Porwit-Ksiazeck et
al., 1983) and IL-4 (Fliedner et al., 1964; Defrance et
al., 1988), appear to play an important role. The
capacity of CD57 cells to produce IL-2, IL-4, and
other cytokines is much debated: Bosseloir et al.,
(1989, 1991) using in situ hybridization failed to
detect any IL-6 or IL-4-secreting cells in tonsil
germinal centers, whereas Butch et al. (1993) say
they have detected IL-4 mRNA in GC T cells.
Currently, we are checking the presence of cyto-
kines in supernatants of CD57 cell cultures and
analyzing mRNA contents of freshly prepared
CD57 T cells.
At this level of our work, we can conclude that
CD57 T cells, contrary to CD57- T cells, whose
effect is strong, exert a very weak effect on B-cell194 F. BOUZAHZAH et al.
proliferation, even on IgD- B cells arising in part in
the germinal centers. This conclusion is in agree-
ment with immunohistological studies showig that
CD57 T cells are predominantly located in the
germinal center light zone. One should remember
that B-cell proliferation occurs mainly in the dark
zone (O’Garra et al., 1988; Freedman et al., 1992),
where few CD57 T cells are found. It has been
suggested that in the light zone, differentiation of B
cells into memory cells or plasma cell precursors is
accompanied by decreased B-cell proliferation
(NoVelle and Snow, 1992). Because CD4+CD57
cells are numerous in the light zone, we reasoned
that they might play a role in curbing the prolifer-
ative activity of dividing B cells coming from the
dark zone. We tested this by coculturing the two
T-cell populations with B cells preactivated for 24
hours with SAC or anti-CD40 combined with anti-
Ig. The CD57- T cells were found to markedly
enhance B-cell proliferation whatever the stimulator
used; CD57 cells, on the contrary, only slightly
increased B-cell proliferation in the presence of SAC
and had no effect on B cells preactivated with anti-Ig
and anti-CD40.
In another series of experiments, we have shown
CD57- T cells to be much more effective than
CD57 cells in inducing B cells to secrete IgM or
IgG. This action of T cells on Ig secretion was largely
dependent upon the mode of stimulation applied.
ConA, for instance was a better inducer of IgM
synthesis than PHA, whereas Ig production was
highest in the presence of IL-2. B cells cultured
alone exhibited only minimal Ig secretion, even in
the presence of exogenous IL-2 combined or not
with ConA or PHA. In fact, Dembech et al. (1992)
report having failed to induce B cells to secrete
significant amounts of Ig by adding various recom-
binant cytokines, such as IL-2, IL-4, IL-6, IFN, all
involved in the proliferation and differentiation of B
cells (O’Garra et al., 1988). Thus, optimal differen-
tiation of human B cells appears to require not only
cytokines, but also close contact with T cells (Reidel
et al., 1988; Whalen et al., 1988; Nolle and Snow,
1992). One of the molecules involved in T-cell-B-
cell contact is CD40. Expression of CD40 ligand
apparently occurs in activated T cells, but expression
of this molecule by GC T cells (CD4/CD57 /)
remains controversial (Spriggs et al., 1993; Van den
Eertwegh et al., 1993).
We have thus defined two populations of tonsillar
CD4 cells that differently affect B-cell proliferation
and Ig production. The functional differences be-
tween the CD4 CD57 and CD4 CD57- popula-
tions may be due to the ability of these cells to
respond to the mitogens used. We are currently
continuing to test the proliferative capacity and the
expression of activation markers by these cells in
response to different mitogens and accessory cells.
Further studies must be conducted to investigate
the function of CD57
/ T cells, notably in cocultures
where follicular dendritic cells are present as well as
centrocytes. Indeed, CD57 cells in the light zone
are adjacent to centrocytes that appear as interme-
diates between activated centroblasts (dark zone)
and quiescent B memory cells (recirculing lympho-
cytes). We hypothesize that CD57 T cells may
contribute to this maturation of centrocytes into B
memory lymphocytes.
MATERIAL AND METHODS
Reagents
Collagenase, dispase, and deoxyribonuclease were
obtained from Boehringer Mannheim and used at
0.005%. Magnetic beads and dynabeads coated with
anti-mouse IgG were purchased respectively from
Miltenyi Biotec (Germany) and Dynal (Norway).
Mitomycin C was purchased from SIGMA and used
at 50 g/ml. Phytohemagglutinin (PHA, 2 tg/ml),
concanavalin A (ConA, 10 tg/ml), and purified
recombinant IL-2 (10 U/ml) were purchased from
Boehringer Mannheim (Germany). Formalinized
particles of Staphylococcus aureus strain Cowan
(SAC) were purchased as pansorbin from
Calbiochem-Behring Corporation (La Jolla, CA) and
used at the final dilution of 1/10,000. Nylon wool
was kindly provided by Dr. Thierry Defrance (Insti-
tut Pasteur de Lyon, France).
Monoclonal Antibodies
PE-conjugated and unconjugated anti-CD19 and
anti-CD8, PE-conjugated anti-CD2 and anti-CD3
mAbs were purchased from DAKO. FITC-
conjugated streptavidin was purchased from Boe-
hringer Mannheim and used at the final dilution of
1/40. Biotin-conjugated anti-CD57 mAb was ob-
tained from Becton Dickinson. Culture supernatants
of OKT3 (anti-CD3 mAb) and OKT 11 (anti-CD2
mAb) hybridoma cell lines and the anti-CD40 mAb
were kindly provided by Dr. E. A. Clark (University
of Washington, Scolt, WA). Rabbit anti-humanGERMINAL CENTER T-HELPER CELLS 195
immunoglobulin coupled to polyacrylamide beads
was purchased from Biorad Laboratories (Rich-
mond, CA) and used at the final dilution of 1/600.
Anti-IgD m Ab (Amersham) was used at the final
dilution of 1/300.
Isolation Procedure of Helper T Cells
Tonsils from 4- to 1-year-old children were surgically
dissected and transported to the laboratory at 4C in
a physiological solution containing 0.4% bovine se-
rum albumin (BSA). The tonsils were then cut into
fragments and treated first with collagenase alone,
then with a mixture of collagenase, dispase, and
deoxyribonuclease.
T cells were separated from other cells by running
the lymphocyte suspensions through nylon wool
columns prepared by packing 50-ml syringes with
nylon wool. Before the cells were added (10
9 cells
per column), the columns were washed at 37C
with RPMI 1640 supplemented with 10% FCS.
After the cells were added, the columns were eluted
with RPMI-10% FCS until the cells had run two-
thirds of the way through them. After incubation
for 1 hour at 37C, the columns were slowly rinsed
with the eluent (RPMI-10% FCS at 37 C) and the
nonadherent T cells recovered. The recovered T cells
were labeled with anti-CD8 and anti-CD19 mAbs
and subsequently incubated with anti-mouse IgG-
coated magnetic beads. The B cells and CD8 cells
were removed by applying a magnetic field for 10
min. The purity of the CD4 T-cell population
exceeded 98%, as estimated by flow cytometry. An
anti-CD57 mAb and a magnetic cell sorter (Becton
Dickinson) were used to sort the CD4 T cells into
CD4 CD57 and CD4 CD57- cells. Briefly, the
CD4 T cells were incubated with biotin-conjugated
anti-CD57 mAb for 30 min, rinsed, and placed in
contact with FITC-conjugated sterptavidin for 10
min. Then they were incubated with biotinylated
magnetic beads before transfer to the separation
column installed in the magnetic field of the MACS
apparatus. The CD57 cells were recovered by
rinsing the column with a physiological solution at
4C outside the magnetic field. As estimated by flow
cytometry, the purity of the CD57 and the CD57-
cells obtained by this procedure exceeded 94 and
96%. These T cells were treated with mitomycin C
at 37C for 45 min, rinsed thrice, then cocultured
with B cells in the presence of PHA or ConA,
combined or not with IL-2.
B-Cell Separation
After enzymatic digestion, tonsillar mononuclear
cells were incubated with 2-aminoethylioso-
thiouronium-bromide-treated SRBC. Nonrosetting
cells were labeled with anti-T-cell mAbs (OKT3,
OKTll) and dynabeads to remove contaminant T
cells. As estimated by flow cytometry with PE-
conjugated mAbs (anti-CD19, anti-CD3, anti-CD2),
the purity of the B-cell populations thus obtained ex-
ceeded 95%. Anti-IgD mAb and MACS were used to
isolate sIgD-B cells; the purity of the sIgD- B cells, as
estimated by flow cytometry, was 80%. All purifica-
tion steps (rosetting, MACS) were performed at 4 C.
Cultures
Cultures were grown in RPMI 1640 supplemented
with 10% FCS, 2 mM L-glutamine, 100 U/ml peni-
cillin, and 100 gg/ml streptomycin.
1 x 105 B cell swere cocultured with 3 x 105 T cells
per well in 96-well microtiter plates in a final volume
of 150 gl (proliferation tests) or 200 gl (differentiation
tests). The T cells were treated before hand with mi-
tomycin C (50 gg/ml) at 37C for 45 min. Different
polyclonal T-cell activators (PHA, ConA, IL-2) were
added to the cultures. To test the capacity of T cells to
suppress B-cell proliferation, we preincubated the .B
cells with SAC or anti-CD40 combined with anti-Ig
for 24 hours prior to addition of T cells.
The cultures were incubated at 37C in a 5%
CO2 enriched atmosphere for 48 hours. A B-cell
proliferation was tested by pulsing the cells with
[3H]thymidine (1 gCi per well) during an additional
16-hour incubation. Results were expressed as means
of triplicate or quadruplicate cultures. To measure Ig
production, we maintained the cultures for 10 days
and analyzed the supernatants by the ELISA tech-
nique as described by Defrance et al. (1988).
Cytolytic Test
The cytolytic activity of CD57 and CD57- T cells
was tested by measuring 51Cr release from human
K562 cells as described by Parker and Martz
(1980). Cytolytic activity was assayed on freshly
isolated CD57 and CD57- cells or on ones pre-
activated for 24 hours with PHA.
Activated peripheral blood lymphocytes (PBL)
were used as positive controls.196 F. BOUZAHZAH et al.
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